<?xml version="1.0" encoding="UTF-8"?>
<p>For the derivation cohort, we prospectively and consecutively recruited patients with a clinical suspicion of PTB without an aetiological evidence (smear microscopy, culture, or nucleic acid amplification test) who were admitted from Dec 2014 to Jan 2017 to the Respiratory and Infection Department of the West China Hospital, Sichuan University. The inclusion criteria included the following: (a) age ≥ 18 years; (b) clinical manifestations &gt; 2 weeks and a disease history with high suspect of PTB. (c) at least two successive AFB sputum smears, one MTB-DNA PCR and one mycobacterium culture were all negative. (d) anti-tuberculosis therapy &lt; 7 days on admission. Clinically diagnosed PTB and non-TB control patients were diagnosed following the Chinese diagnostic criteria for PTB by two experienced pulmonologists separately (The National Health and Family Planning Commission, WS 288–2017).</p>
